Skip to main content
Erin Bohula, MD, Cardiology, Boston, MA

Erin Ann Bohula MD

Adult Congenital Heart Disease


Cardiologist, Brigham and Women's Hospital; Investigator, TIMI Study Group

Join to view full profile
  • 75 Francis StBoston, MA 02115

  • Phone+1 617-732-6660

Dr. Bohula is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2010 - 2013
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
  • Harvard Medical School
    Harvard Medical SchoolClass of 2007

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2027
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients  
    Erin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
  • Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients  
    Christina L. Fanola, Darren K. McGuire, Silvio E. Inzucchi, Erin A. Bohula, The New England Journal of Medicine

Lectures

  • Acute Cardiogenic Shock: Progress Paradigms and Problems 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Audience ARS Question 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • CAMELLIA-TIMI 61 Trial 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

  • Time to Overcome PCSK9i Inertia: New Data, Future Options
    Time to Overcome PCSK9i Inertia: New Data, Future OptionsNovember 24th, 2025
  • Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke - VESALIUS-CV
    Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke - VESALIUS-CVNovember 21st, 2025
  • Evolocumab Reduces Cardiac Events in High-Risk Patients Without Prior MI or Stroke: NEJM
    Evolocumab Reduces Cardiac Events in High-Risk Patients Without Prior MI or Stroke: NEJMNovember 19th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: